More Than 100 Applications Lost Equivalence Rating Thanks To Allegedly Falsified Data At Two CROs

 
• By Derrick Gingery
computer security
Because the data integrity of some studies came into question, the FDA said all data from two CROs was not reliable. • Source: Alamy

More from Generics

More from Biosimilars & Generics